dabigatran has been researched along with Osteoarthritis, Hip in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink, B; Mayer, A; Schuster, P | 1 |
Akhtyamov, IF; Shigaev, ES; Ziatdinov, BG | 1 |
2 other study(ies) available for dabigatran and Osteoarthritis, Hip
Article | Year |
---|---|
A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Postoperative Complications; Pyrazoles; Pyridones; Thrombosis; Treatment Outcome | 2017 |
[Substantiation of the system of thrombus formation prevention in treatment of patients with hip joint pathology against the background of arterial insufficiency of the lower extremities].
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Arthroplasty, Replacement, Hip; Blood Coagulation; Dabigatran; Enoxaparin; Female; Humans; Lower Extremity; Male; Middle Aged; Osteoarthritis, Hip; Perioperative Care; Postoperative Complications; Retrospective Studies; Risk Adjustment; Russia; Thrombosis | 2016 |